Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...

Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation requirements for its U.S. business ...

Obesity drugmaker Novo Nordisk cut its sales forecasts on Wednesday for the first time since the launch of its Wegovy ...

Teva Pharmaceutical Industries reported a slightly larger than expected rise in first-quarter profit, helped by strong sales ...

U.S. Agriculture Secretary Brooke Rollins said during a hearing in the House of Representatives on Wednesday that new dietary ...

India's central bank on Wednesday laid down a framework to standardise the process of making and amending rules, including ...

The European Union's health regulator said on Wednesday it was reviewing Valneva's chikungunya vaccine after reports of ...

The National Institutes of Health and the Centers for Medicare & Medicaid Services have partnered to enable research around ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and diabetes drugs Zepbound and Mounjaro off a list of medicines in short supply, ...

Jeff Bezos' personal firm Bezos Expeditions is leading a $72-million investment in artificial intelligence data solutions ...

HSBC has launched a new financing tool for U.S. clients to pay import duties following the imposition of sweeping tariffs by ...

Japanese drugmaker Shionogi plans to acquire Torii Pharmaceutical for about 150 billion yen ($1.01 billion), the Nikkei ...